[go: up one dir, main page]

ES427177A1 - Metodo de preparacion de glucoronilglucosamin-glican-sulfa-tos de actividad antilipemica. - Google Patents

Metodo de preparacion de glucoronilglucosamin-glican-sulfa-tos de actividad antilipemica.

Info

Publication number
ES427177A1
ES427177A1 ES427177A ES427177A ES427177A1 ES 427177 A1 ES427177 A1 ES 427177A1 ES 427177 A ES427177 A ES 427177A ES 427177 A ES427177 A ES 427177A ES 427177 A1 ES427177 A1 ES 427177A1
Authority
ES
Spain
Prior art keywords
antilipasaemic
glucosamino
glycan
preparing
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES427177A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Opocrin SpA
Original Assignee
Opocrin SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opocrin SpA filed Critical Opocrin SpA
Publication of ES427177A1 publication Critical patent/ES427177A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • C07H1/08Separation; Purification from natural products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/38Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/08Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
    • C07H5/10Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES427177A 1973-06-14 1974-06-11 Metodo de preparacion de glucoronilglucosamin-glican-sulfa-tos de actividad antilipemica. Expired ES427177A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2537173 1973-06-14

Publications (1)

Publication Number Publication Date
ES427177A1 true ES427177A1 (es) 1976-07-16

Family

ID=11216494

Family Applications (1)

Application Number Title Priority Date Filing Date
ES427177A Expired ES427177A1 (es) 1973-06-14 1974-06-11 Metodo de preparacion de glucoronilglucosamin-glican-sulfa-tos de actividad antilipemica.

Country Status (9)

Country Link
US (1) US3936351A (es)
JP (1) JPS5035398A (es)
AR (1) AR201869A1 (es)
AU (1) AU7015174A (es)
CA (1) CA1015269A (es)
DE (1) DE2426586A1 (es)
ES (1) ES427177A1 (es)
FR (1) FR2233332A1 (es)
GB (1) GB1436684A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3422407A1 (de) * 1984-06-16 1986-03-06 B. Braun Melsungen Ag, 3508 Melsungen Verwendung von heparinderivaten zur selektiven extrakorporalen praezipitation von low-density-lipoproteinen aus vollserum oder plasma
EP0421508B1 (en) * 1989-10-04 1993-12-15 Akzo Nobel N.V. Sulphated glycosaminoglycuronan with antithrombotic activity
RU2139715C1 (ru) * 1999-02-23 1999-10-20 Ларионов Евгений Викторович Способ получения солей гликозаминогликанов
RU2162331C1 (ru) * 2000-04-21 2001-01-27 Панасюк Андрей Федорович Способ получения сульфатированных гликозаминогликанов
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
US20030008844A1 (en) * 2001-05-17 2003-01-09 Keryx Biopharmaceuticals, Inc. Use of sulodexide for the treatment of inflammatory bowel disease
US7943594B2 (en) * 2002-07-10 2011-05-17 Massachusetts Institute Of Technology Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans
RU2273486C1 (ru) * 2004-08-17 2006-04-10 Андрей Федорович Панасюк Способ выделения сульфатированных гликозаминогликанов из биологических тканей
RU2304441C1 (ru) * 2005-10-27 2007-08-20 Дмитрий Алексеевич Саващук Способ получения сульфатированных гликозаминогликанов из биологических тканей
IT1401253B1 (it) 2010-04-23 2013-07-18 Uni Degli Studi Carlo Bo Urbino Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
EP3997238A1 (en) 2019-07-09 2022-05-18 Optimvia, LLC Methods for synthesizing anticoagulant polysaccharides
RU2759517C9 (ru) * 2021-04-02 2022-01-20 Общество с ограниченной ответственностью "АВЕО" Способ получения фармацевтических сульфатированных гликозаминогликанов из биологических тканей

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000787A (en) * 1957-11-06 1961-09-19 Crinos Industria Farmaco Heparinoid anticholestrolemic factor
GB889010A (en) * 1957-11-06 1962-02-07 Crinos Industria Farmaco A new heparin-like compound
US3174903A (en) * 1961-09-14 1965-03-23 Szabo Hnos Kessler & Cia S R L Preparation of heparinoids
LU53450A1 (es) * 1966-07-22 1967-06-19
US3810978A (en) * 1971-12-06 1974-05-14 Taiho Pharmaceutical Co Ltd Process for producing antilipemic substance

Also Published As

Publication number Publication date
US3936351A (en) 1976-02-03
AR201869A1 (es) 1975-04-24
DE2426586A1 (de) 1975-01-09
GB1436684A (en) 1976-05-19
AU7015174A (en) 1975-12-18
JPS5035398A (es) 1975-04-04
FR2233332A1 (es) 1975-01-10
CA1015269A (en) 1977-08-09

Similar Documents

Publication Publication Date Title
ES427177A1 (es) Metodo de preparacion de glucoronilglucosamin-glican-sulfa-tos de actividad antilipemica.
PH10596A (en) Recovery of zinc from zinc sulphates by direct pressure leaching
FR2348942A1 (fr) Procede de preparation de perles de cellulose poreuses
BE824441A (fr) Procede de production d'alpha-galactosidase
BE828697A (fr) Procede de recuperation d'alpha-galactosidase raffinee
AT322572B (de) Verfahren zur herstellung von mischungen neuer alkali- oder erdalkalimetallsalze von dithiocarbaminsäuren
CH545331A (de) Verfahren zur kontinuierlichen Herstellung von wässerigen Paraffinemulsionen
GB1342344A (en) Purification of phosphoric acid
BR7403316D0 (pt) Aperfeicoamento em processo de producao de produtos recozidos
IE37970B1 (en) Azomethines of 4-amino-5-h-1,2,4-triazin-5-ones process for their production and their use as herbicides
BE749139A (fr) Roches magmatiques artificielles et procede pour les produire
BE750479A (fr) Procede pour la production industrielle de pommes de terre frites
BE796895A (fr) Derives de l'acide thiocarbamique et procede pour les preparer
BE777712R (fr) Dispositif de production d'une difference de potentiel continueelevee
IT979160B (it) Processo per la produzione di soluzioni di policarbonato
CH536876A (fr) Procédé de récupération d'argent
IT1006621B (it) Processo per la produzione di cloroprene e prodotto in tal mo do ottenuto
BE811812A (fr) Procede de solidification de metal en fusion et produit resultant
GB1387592A (en) Process for preparing an interferon inducer
CH516284A (de) Kontinuierliches mehrstufiges Verfahren zur Herstellung von Kaffee-Extrakt nach dem Filtrationsprinzip
CH538282A (de) Verfahren zur Herstellung von Pflanzenextraktkonzentraten
IL35453A (en) Method for selectively destroying weeds in cultivated crops by means of n-p-tert-butylphenyl-n',n'-dimethylurea
BE759200A (fr) Procede de production d'emulsion d'halogenure d'argent de sensibilite elevee
IL34394A (en) Method for influencing the growth of plants by using aliphatic dithiocarbamates
BE752682A (fr) Procede de preparation d'amino-2 pyridines